Bay Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Sell
1,466
-1
-0.1% -$1.02K 0.94% 21
2026
Q1
$1.35M Sell
1,467
-14
-0.9% -$14.2K 0.83% 22
2025
Q4
$1.59M Buy
1,481
+2
+0.1% +$1.91K 0.97% 22
2025
Q3
$1.13M Sell
1,479
-3
-0.2% -$2.23K 0.73% 25
2025
Q2
$1.16M Sell
1,482
-49
-3% -$38.1K 0.88% 23
2025
Q1
$1.26M Buy
1,531
+4
+0.3% +$3.33K 1.05% 20
2024
Q4
$1.18M Buy
+1,527
New +$1.26M 0.95% 23

Other funds holding LLY

Bay Capital Advisors's LLY Position: Q2 2026 in Review

Bay Capital Advisors reduced its Eli Lilly (LLY) stake by 0.07% in Q2 2026, selling an estimated $1.02K and leaving 1,466 shares worth $1.76M. The position accounts for 0.94% of the portfolio, ranked #21.

Bay Capital Advisors first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bay Capital Advisors held 1,466 shares of Eli Lilly worth $1.76M as of Q2 2026.
  • Bay Capital Advisors sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.94% of Bay Capital Advisors's portfolio in Q2 2026, its #21 holding.
  • Bay Capital Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bay Capital Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.